CARDIFF ONCOLOGY, INC. Investment Income, Interest
CARDIFF ONCOLOGY, INC. (CRDF) reported Investment Income, Interest of $382.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-11
- CARDIFF ONCOLOGY, INC. investment income, interest for the quarter ending 2026-06-30 was $382.00K, a 54.25% decline year-over-year.
- CARDIFF ONCOLOGY, INC. investment income, interest for the quarter ending 2026-03-31 was $506.00K, a 46.23% decline year-over-year.
- CARDIFF ONCOLOGY, INC. investment income, interest for the quarter ending 2025-12-31 was $612.00K, a 22.24% decline year-over-year.
- CARDIFF ONCOLOGY, INC. investment income, interest for the quarter ending 2025-09-30 was $716.00K, a 3.37% decline year-over-year.
- CARDIFF ONCOLOGY, INC. investment income, interest for fiscal 2025 was $3.10M, a 4.76% decline from fiscal 2024.
- CARDIFF ONCOLOGY, INC. investment income, interest for fiscal 2024 was $3.26M, a 19.91% decline from fiscal 2023.
- CARDIFF ONCOLOGY, INC. investment income, interest for fiscal 2023 was $4.07M, a 157.37% increase from fiscal 2022.
- CARDIFF ONCOLOGY, INC. investment income, interest for fiscal 2022 was $1.58M, a 498.86% increase from fiscal 2021.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month | Investment Income, Interest 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $382.00K 10-Q · filed 2026-08-11 | $888.00K 10-Q · filed 2026-08-11 | $1.50M derived: sum of 3 quarters · filed 2026-08-11 | $2.22M derived: sum of 4 quarters · filed 2026-08-11 | |
| 2026-03-31 | $506.00K 10-Q · filed 2026-05-14 | $1.12M derived: sum of 2 quarters · filed 2026-05-14 | $1.83M derived: sum of 3 quarters · filed 2026-05-14 | $2.67M derived: sum of 4 quarters · filed 2026-08-11 | |
| 2025-12-31 | $612.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $1.33M derived: sum of 2 quarters · filed 2026-02-24 | $2.16M derived: sum of 3 quarters · filed 2026-08-11 | $3.10M 10-K · filed 2026-02-24 | |
| 2025-09-30 | $716.00K 10-Q · filed 2025-11-06 | $1.55M derived: sum of 2 quarters · filed 2026-08-11 | $2.49M 10-Q · filed 2025-11-06 | $3.28M derived: sum of 4 quarters · filed 2026-08-11 | |
| 2025-06-30 | $835.00K 10-Q · filed 2026-08-11 | $1.78M 10-Q · filed 2026-08-11 | $2.56M derived: sum of 3 quarters · filed 2026-08-11 | $3.30M derived: sum of 4 quarters · filed 2026-08-11 | |
| 2025-03-31 | $941.00K 10-Q · filed 2026-05-14 | $1.73M derived: sum of 2 quarters · filed 2026-05-14 | $2.47M derived: sum of 3 quarters · filed 2026-05-14 | $3.27M derived: sum of 4 quarters · filed 2026-05-14 | |
| 2024-12-31 | $787.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $1.53M derived: sum of 2 quarters · filed 2026-02-24 | $2.33M derived: sum of 3 quarters · filed 2026-02-24 | $3.26M 10-K · filed 2026-02-24 | |
| 2024-09-30 | $741.00K 10-Q · filed 2025-11-06 | $1.55M derived: sum of 2 quarters · filed 2025-11-06 | $2.47M 10-Q · filed 2025-11-06 | $3.48M derived: sum of 4 quarters · filed 2025-11-06 | |
| 2024-06-30 | $805.00K 10-Q · filed 2025-07-29 | $1.73M 10-Q · filed 2025-07-29 | $2.74M derived: sum of 3 quarters · filed 2025-07-29 | $3.81M derived: sum of 4 quarters · filed 2025-07-29 | |
| 2024-03-31 | $926.00K 10-Q · filed 2025-05-08 | $1.93M derived: sum of 2 quarters · filed 2025-05-08 | $3.00M derived: sum of 3 quarters · filed 2025-05-08 | $4.05M derived: sum of 4 quarters · filed 2025-05-08 | |
| 2023-12-31 | $1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $2.08M derived: sum of 2 quarters · filed 2025-02-27 | $3.13M derived: sum of 3 quarters · filed 2025-02-27 | $4.07M 10-K · filed 2025-02-27 | |
| 2023-09-30 | $1.07M 10-Q · filed 2024-11-07 | $2.12M derived: sum of 2 quarters · filed 2024-11-07 | $3.06M 10-Q · filed 2024-11-07 | ||
| 2023-06-30 | $1.05M 10-Q · filed 2024-08-08 | $1.99M 10-Q · filed 2024-08-08 | |||
| 2022-12-31 | $1.58M 10-K · filed 2024-02-29 | ||||
| 2021-12-31 | $264.00K 10-K · filed 2023-03-02 | ||||
| 2020-12-31 | $90.00K 10-K · filed 2022-02-24 | $89.81K 10-K · filed 2021-02-25 | |||
| 2019-12-31 | $234.17K 10-K · filed 2021-02-25 | ||||
| 2018-12-31 | $219.43K 10-K · filed 2020-02-27 | ||||
| 2017-12-31 | $147.88K 10-K · filed 2019-03-06 | ||||
| 2016-12-31 | $298.83K 10-K · filed 2018-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |